Logo-bi
Original Research
Daria Franskevych ORCID, Svitlana Prylutska* ORCID, Iryna Grynyuk ORCID, Ganna Pasichnyk ORCID, Liudmyla Drobot ORCID, Olga Matyshevska ORCID, Uwe Ritter ORCID
Bioimpacts. 2019;9(4): 211-217. doi: 10.15171/bi.2019.26
PMCID: PMC6879712     PMID: 31799157     Scopus ID: 85077126162    
Synergic cytotoxic activity of photoexcited C60 fullerene and cisplatin in a low concentration against leukemic L1210 cells resistant to cisplatin was established. The activation of p38 MAP kinase, decrease of mitochondrial membrane potential and L1210R cells accumulation in subG1 phase were found.
Original Article
Megha Gautam ORCID, Reema Gabrani* ORCID
Bioimpacts. 2024;14(5): 27681. doi: 10.34172/bi.2023.27681
PMCID: PMC11406426     PMID: 39296804     Scopus ID: 85201930273    
Original Article
Ali Zeiz ORCID, Ranin Kawtharani, Mirvat Elmasri, Ghada Khawaja, Eva Hamade, Aida Habib, Abeer J. Ayoub, Mohamed Abarbri, Mohammad H. El-Dakdouki* ORCID
Bioimpacts. 2024;14(2): 27688. doi: 10.34172/bi.2023.27688
PMCID: PMC10945296     PMID: 38505674     Scopus ID: 85175870676    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge